Dasatinib - Wikipedia

Medical uses. Dasatinib is used to treat people with chronic myeloid leukemia and people with acute lymphoblastic leukemia who are positive for the Philadelphia chromosome.

Dasatinib | Src inhibitor | Read Reviews & Product Use ...

Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of 1 nM, 0.8 nM and 79 nM in cell-free assays, respectively.

Dasatinib | Src 抑制剂 | 现货供应 | 美国品牌 ...

Dasatinib是一种新型有效的多靶点抑制剂，作用于Abl，Src和 c-Kit，在无细胞试验中IC50分别为 <1 nM，0.8 nM 和 79 nM。

Dasatinib, nilotinib and high-dose imatinib for treating ...

Evidence-based recommendations on dasatinib (Sprycel), nilotinib (Tasigna) and high-dose imatinib (Glivec) for treating imatinib-resistant or intolerant chronic myeloid leukaemia in adults. This guidance is a Cancer Drugs Fund reconsideration of dasatinib, high-dose imatinib and nilotinib for the

Dasatinib, nilotinib and imatinib for untreated chronic ...

Evidence-based recommendations on dasatinib (Sprycel), nilotinib (Tasigna) and imatinib (Glivec) for untreated chronic myeloid leukaemia in adults

Dasatinib in Imatinib-Resistant Philadelphia Chromosome ...

Background The BCR-ABL tyrosine kinase inhibitor imatinib is effective in Philadelphia chromosome–positive (Ph-positive) leukemias, but relapse occurs, mainly as a result of the outgrowth of leukemic subclones with imatinib-resistant BCR-ABL mutations. We evaluated dasatinib, a BCR-ABL inhibitor that targets most imatinib-resistant BCR-ABL ...

Dasatinib - Drug Information - Chemocare

Dasatinib (SPRYCEL) tyrosine kinase inhibitor targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of leukemia

SPRYCEL® (dasatinib) | SPRYCEL.com

INDICATIONS AND USAGE. SPRYCEL ® (dasatinib) is a prescription medicine used to treat: adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody ...

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

PATIENT INFORMATION SPRYCEL (Spry-sell) (dasatinib ...

Before taking SPRYCEL, tell your healthcare provider about all of your medical conditions, including if you: